Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: Q4QFV5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 137 | 141 | PF00656 | 0.595 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 195 | 197 | PF00675 | 0.484 |
CLV_NRD_NRD_1 | 82 | 84 | PF00675 | 0.742 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.499 |
CLV_PCSK_KEX2_1 | 195 | 197 | PF00082 | 0.484 |
CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.672 |
CLV_PCSK_PC1ET2_1 | 120 | 122 | PF00082 | 0.499 |
DOC_MAPK_gen_1 | 195 | 203 | PF00069 | 0.407 |
DOC_MAPK_gen_1 | 227 | 233 | PF00069 | 0.519 |
DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.537 |
DOC_USP7_MATH_1 | 149 | 153 | PF00917 | 0.653 |
DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.443 |
DOC_USP7_UBL2_3 | 17 | 21 | PF12436 | 0.546 |
DOC_USP7_UBL2_3 | 228 | 232 | PF12436 | 0.517 |
DOC_WW_Pin1_4 | 144 | 149 | PF00397 | 0.667 |
DOC_WW_Pin1_4 | 42 | 47 | PF00397 | 0.532 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.652 |
LIG_14-3-3_CanoR_1 | 195 | 200 | PF00244 | 0.465 |
LIG_14-3-3_CanoR_1 | 96 | 100 | PF00244 | 0.633 |
LIG_Actin_WH2_2 | 174 | 191 | PF00022 | 0.516 |
LIG_APCC_ABBA_1 | 99 | 104 | PF00400 | 0.536 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.635 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.448 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.478 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.433 |
LIG_FHA_2 | 42 | 48 | PF00498 | 0.505 |
LIG_FHA_2 | 58 | 64 | PF00498 | 0.356 |
LIG_LIR_Gen_1 | 209 | 216 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 49 | 59 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 198 | 203 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 209 | 213 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 214 | 220 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 49 | 55 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.534 |
LIG_NRBOX | 71 | 77 | PF00104 | 0.521 |
LIG_Pex14_1 | 4 | 8 | PF04695 | 0.621 |
LIG_Pex14_2 | 206 | 210 | PF04695 | 0.443 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.500 |
LIG_SH2_SRC | 102 | 105 | PF00017 | 0.534 |
LIG_SH2_STAP1 | 8 | 12 | PF00017 | 0.548 |
LIG_SH2_STAT3 | 161 | 164 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.372 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.500 |
LIG_SH3_3 | 106 | 112 | PF00018 | 0.785 |
LIG_TYR_ITIM | 50 | 55 | PF00017 | 0.500 |
MOD_CDC14_SPxK_1 | 80 | 83 | PF00782 | 0.567 |
MOD_CDK_SPK_2 | 77 | 82 | PF00069 | 0.652 |
MOD_CDK_SPxK_1 | 77 | 83 | PF00069 | 0.592 |
MOD_CK1_1 | 143 | 149 | PF00069 | 0.571 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.482 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.577 |
MOD_CK1_1 | 87 | 93 | PF00069 | 0.730 |
MOD_CK2_1 | 102 | 108 | PF00069 | 0.699 |
MOD_CK2_1 | 129 | 135 | PF00069 | 0.730 |
MOD_CK2_1 | 206 | 212 | PF00069 | 0.453 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.569 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.371 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.668 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.739 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.705 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.471 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.529 |
MOD_NEK2_1 | 177 | 182 | PF00069 | 0.450 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.500 |
MOD_NEK2_2 | 129 | 134 | PF00069 | 0.536 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.590 |
MOD_PIKK_1 | 201 | 207 | PF00454 | 0.251 |
MOD_PKA_1 | 195 | 201 | PF00069 | 0.459 |
MOD_PKA_2 | 195 | 201 | PF00069 | 0.459 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.581 |
MOD_Plk_1 | 211 | 217 | PF00069 | 0.450 |
MOD_Plk_2-3 | 187 | 193 | PF00069 | 0.468 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.466 |
MOD_Plk_4 | 195 | 201 | PF00069 | 0.427 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.513 |
MOD_ProDKin_1 | 144 | 150 | PF00069 | 0.660 |
MOD_ProDKin_1 | 42 | 48 | PF00069 | 0.534 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.662 |
MOD_SUMO_for_1 | 226 | 229 | PF00179 | 0.509 |
TRG_DiLeu_BaEn_1 | 221 | 226 | PF01217 | 0.488 |
TRG_DiLeu_BaEn_2 | 167 | 173 | PF01217 | 0.375 |
TRG_DiLeu_BaLyEn_6 | 71 | 76 | PF01217 | 0.514 |
TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.493 |
TRG_ER_diArg_1 | 81 | 83 | PF00400 | 0.730 |
TRG_Pf-PMV_PEXEL_1 | 74 | 78 | PF00026 | 0.502 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3F1 | Leptomonas seymouri | 56% | 67% |
A0A3Q8IBX5 | Leishmania donovani | 95% | 100% |
A4H7I9 | Leishmania braziliensis | 85% | 78% |
A4HVX2 | Leishmania infantum | 95% | 100% |
C9ZT50 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9APM3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
V5AXT5 | Trypanosoma cruzi | 32% | 100% |